Alpha 2.0
Login Register
» Articles » PMID: 28821479

Psychotropic Prescribing in People with Intellectual Disability and Challenging Behaviour

Overview
Journal BMJ
Specialty General Medicine
Date 2017 Aug 20
PMID 28821479
Citations 9
Authors
Rory Sheehan
Andre Strydom
Nicola Morant
Elisavet Pappa
Angela Hassiotis
Affiliations
Soon will be listed here.
Citing Articles

The potential for medicinal cannabis to help manage challenging behaviour in people with intellectual disability: A perspective review.

Korb L, Tromans S, Perera B, Khan N, Burrows L, Laugharne R J Psychopharmacol. 2023; 37(12):1201-1208.

PMID: 37937428 PMC: 10714688. DOI: 10.1177/02698811231209192.

Medicinal Cannabis for Paediatric Developmental, Behavioural and Mental Health Disorders.

Efron D, Taylor K Int J Environ Res Public Health. 2023; 20(8).

PMID: 37107712 PMC: 10138057. DOI: 10.3390/ijerph20085430.

COVID-19 pandemic impact on psychotropic prescribing for adults with intellectual disability: an observational study in English specialist community services.

Naqvi D, Perera B, Mitchell S, Sheehan R, Shankar R BJPsych Open. 2021; 8(1):e7.

PMID: 34865678 PMC: 8649353. DOI: 10.1192/bjo.2021.1064.

Community-Based Support and Social Services and Their Association with Frailty Factors in Older People with Intellectual Disability and Affective and Anxiety Disorders: A Swedish National Population-Based Register Study.

El Mrayyan N, Bokberg C, Eberhard J, Ahlstrom G Community Ment Health J. 2021; 58(5):1000-1013.

PMID: 34750683 PMC: 9187569. DOI: 10.1007/s10597-021-00909-3.

An Exploratory Study among Intellectual Disability Physicians on the Care and Coercion Act and the Use of Psychotropic Drugs for Challenging Behaviour.

Bij de Weg J, Honingh A, Teeuw M, Sterkenburg P Int J Environ Res Public Health. 2021; 18(19).

PMID: 34639540 PMC: 8547136. DOI: 10.3390/ijerph181910240.